Remote Jobs at Tubulis GmbH
Tubulis GmbH
Biotechnology • Pharmaceuticals
Tubulis GmbH is a biotechnology company specializing in the design and development of next-generation antibody–drug conjugates (ADCs) for cancer treatment. The company leverages proprietary platform technologies to generate uniquely matched ADCs with improved biophysical properties, durable on-tumor delivery, and strong preclinical anti-tumor activity. Its lead clinical programs, TUB-040 (anti-NaPi2b) and TUB-030 (anti-5T4), target high-need solid tumor indications, and Tubulis advances both its proprietary pipeline and partnered programs with the aim of expanding the therapeutic potential of ADCs for patients and collaborators.
51 - 200 employees
🧬 Biotechnology
đź’Š Pharmaceuticals
October 29
Job not on LinkedIn
European Patent Attorney responsible for IP management and patent prosecution for cancer treatment technologies at Tubulis. Collaborating globally to innovate and advance targeted therapeutics.
October 16
Job not on LinkedIn
QC Manager overseeing stability studies and method qualifications for biopharmaceuticals in an innovative company. Collaborating with internal teams and contract manufacturing organizations for results certification.
🗣️🇩🇪 German Required
October 13
Associate Medical Director contributing to antibody-drug conjugates global clinical trials at Tubulis. Leading clinical aspects, ensuring patient safety, and supporting medical development processes.
October 13
Clinical Scientist managing clinical trial data and documentation for oncology research. Collaborating with cross-functional teams for global clinical studies in a fast-growing biotech company.
🗣️🇩🇪 German Required
October 13
Job not on LinkedIn
Director of Clinical Supply Management leading global supply chain for clinical trial materials. Ensuring timely delivery and compliance while supporting Tubulis’ mission to advance targeted cancer therapies.
October 13
Job not on LinkedIn
Associate Director of Operational Excellence leading GCP compliance in clinical trials at Tubulis, a biotech focusing on innovative cancer therapies.
